Please use this identifier to cite or link to this item:
Title: Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
Authors: Amiel, Stephanie A.
Aschner, Pablo
Childs, Belinda
Cryer, Philip E.
de Galan, Bastiaan E.
Heller, Simon R.
Frier, Brian M.
Gonder-Frederick, Linda
Jones, Timothy
Khunti, Kamlesh
Leiter, Lawrence A.
McCrimmon, Rory J.
Luo, Yingying
Seaquist, Elizabeth R.
Vigersky, Robert
Zoungas, Sophia
First Published: 21-Nov-2016
Publisher: Springer Verlag
Citation: Diabetologia, 2017, 60 (1), pp. 3-6
DOI Link: 10.1007/s00125-016-4146-6
ISSN: 0012-186X
eISSN: 1432-0428
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © the authors, 2016. This is an open-access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
File Description SizeFormat 
art%3A10.1007%2Fs00125-016-4146-6.pdfPublished (publisher PDF)309.66 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.